Rejection decision explanations in the perspective of fairness theory

F. Rolland(Institut de Cancérologie de l'Ouest), Dirk D. Steiner(Université Côte d'Azur)

PsycEXTRA Dataset

January 1, 2007

10.1037/e518532013-222

Cited by 1

Related Papers

Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.

|PubMed|1998|114

LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial

|Annals of Oncology|2021|87

Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): Preliminary results of the randomized phase II TREMPLIN study

|Journal of Clinical Oncology|2009|80

Efficacy of lapatinib in patients with high tumor EGFR expression: Results of a phase III trial in advanced renal cell carcinoma (RCC)

|Journal of Clinical Oncology|2006|58

Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck

|European Journal of Cancer|2004|42